Literature DB >> 4315990

The action of angiotensin on the human colon in vitro.

D J Fishlock, A Gunn.   

Abstract

1. The action of angiotensin on the circular and longitudinal muscle of the human colon has been studied in vitro. The ED50 value (g/ml) of circular muscle was 8.7 x 10(-8) and of longitudinal muscle 3.1 x 10(-8), while the corresponding figures for acetylcholine were 1.6 x 10(-6) and 1.1 x 10(-6), respectively. Angiotensin caused a sustained contraction associated with prolonged tachyphylaxis.2. As the action of angiotensin was not antagonized by atropine, hexa-methonium or procaine, angiotensin appeared to act directly on the smooth muscle of the human colon.3. Lidoflazine is not a specific antagonist of angiotensin.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4315990      PMCID: PMC1702935          DOI: 10.1111/j.1476-5381.1970.tb09553.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Effects of bradykinin and angiotensin on smooth muscle.

Authors:  P A KHAIRALLAH; I H PAGE
Journal:  Ann N Y Acad Sci       Date:  1963-02-04       Impact factor: 5.691

2.  Action of angiotensin on isolated guinea pig ileum.

Authors:  C A ROSS; C T LUDDEN; C A STONE
Journal:  Proc Soc Exp Biol Med       Date:  1960-12

3.  Stimulation of intestinal nervous elements by angiotensin.

Authors:  P A ROBERTSON; D RUBIN
Journal:  Br J Pharmacol Chemother       Date:  1962-08

4.  The effect of 5-hydroxytryptamine on the human ileum and colon in vitro.

Authors:  D J Fishlock; A G Parks
Journal:  Br J Pharmacol Chemother       Date:  1966-11

5.  Specific antagonism to the direct and indirect action of angiotensin on isolated guinea-pig ileum.

Authors:  T Godfraind; A Kaba; P Polster
Journal:  Br J Pharmacol Chemother       Date:  1966-10

6.  Angiotensin tachyphylaxis and its reversal.

Authors:  P A Khairallah; I H Page; F M Bumpus; R K Türker
Journal:  Circ Res       Date:  1966-08       Impact factor: 17.367

7.  The effect of 5-hydroxytryptamine on the human colon in vivo and in vitro.

Authors:  J J Misiewicz; S L Waller
Journal:  Proc R Soc Med       Date:  1967-03

8.  The action of nicotine on the circular muscle of the human ileum and colon in vitro.

Authors:  D J Fishlock; A G Parks
Journal:  Br J Pharmacol Chemother       Date:  1966-01

9.  Some observations on the response of normal human sigmoid colon to drugs in vitro.

Authors:  P G Wright; J J Shepherd
Journal:  Gut       Date:  1966-02       Impact factor: 23.059

10.  A PRELIMINARY INVESTIGATION OF THE PHARMACOLOGY OF THE HUMAN ISOLATED TAENIA COLI PREPARATION.

Authors:  A BUCKNELL; B WHITNEY
Journal:  Br J Pharmacol Chemother       Date:  1964-08
  10 in total
  5 in total

Review 1.  Pharmacology of colonic muscle.

Authors:  A Bennett
Journal:  Gut       Date:  1975-04       Impact factor: 23.059

2.  miR-802 regulates human angiotensin II type 1 receptor expression in intestinal epithelial C2BBe1 cells.

Authors:  Sarah E Sansom; Gerard J Nuovo; Mickey M Martin; Sainath R Kotha; Narasimham L Parinandi; Terry S Elton
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-17       Impact factor: 4.052

Review 3.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

Review 4.  Elucidating the Association Between the Upregulation of Angiotensin Type 1-Receptors and the Development of Gastrointestinal Malignancies.

Authors:  Mohammad-Hassan Arjmand
Journal:  J Gastrointest Cancer       Date:  2020-11-10

Review 5.  Review article: the pathophysiological roles of the renin-angiotensin system in the gastrointestinal tract.

Authors:  M Garg; P W Angus; L M Burrell; C Herath; P R Gibson; J S Lubel
Journal:  Aliment Pharmacol Ther       Date:  2012-01-05       Impact factor: 8.171

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.